Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will ...
News Medical on MSN11h
New immune map uncovers key pancreatic cancer insightsResearchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...
The Healthy @Reader's Digest on MSN6h
“Here’s How I Knew I Had Pancreatic Cancer”: One Survivor’s Story After Years of Growing CluesA pancreatic cancer diagnosis can be startling. One young survivor, who battled this disease during the COVID-19 pandemic, ...
Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
Pancreatic cancer is one of the deadliest types of cancer, with very few people surviving for more than five years after ...
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...
The FDA has granted Fast Track designation to amezalpat (TPST-1120) for the treatment of patients with hepatocellular carcinoma.
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback